Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06199817
Other study ID # 16-5.1/7
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2016
Est. completion date August 19, 2022

Study information

Verified date December 2023
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder. Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. The intervention group participated in routine community mental health center services and a total of 24 sessions of occupational therapies three times a week, while the control group participated in routine community mental health center services.


Description:

Background: Occupational therapies are one of the psycho-social intervention methods used in the treatment of serious mental disorders characterized by disability, such as schizophrenia. Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder. Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. The intervention group participated in routine community mental health center services and a total of 24 sessions of occupational therapies three times a week, while the control group participated in routine community mental health center services. Data were collected using the Subjective Recovery Assessment Scale and the Functional Remission of General Schizophrenia Scale.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date August 19, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Being in the 18-65 age group - have been diagnosed with schizophrenia for at least one year - be in remission of the disease - volunteering to participate in research - not have any physical health problems that would prevent their participation in the research Exclusion Criteria: - have a physical health problem that prevents participation in the research - Having a communication problem - not willing to participate in research

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
occupational therapies
music, garden-soil and sports practices for individuals diagnosed with schizophrenic disorder

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Outcome

Type Measure Description Time frame Safety issue
Other Functional Remission of General Schzophrenia Scale (Follow Up Test) The scale is a 5-point Likert type scale consisting of 19 items. The minimum score obtained from the scale is 19 points and the maximum score is 95 points. High scores from the scale indicate high functionality, while low scores from the scale indicate low functionality. "Functional Remission of General Schzophrenia Scale" score was expected to increase in the follow up test. Seventh month
Other Subjective Recovery Assessment Scale (Follow Up Test) The scale is a 5-point Likert type consisting of 17 items. The lowest score from the scale is 17 and the highest score is 85. Higher scores from the scale indicate that the individual perceives himself as more improved. It was expected that the score obtained from the scale in the follow-up test would be high. Seventh month
Other Effect Size of Functional Remission of General Schzophrenia Scale It shows how the applied occupational therapies affect the final and follow-up test scale scores of the intervention and control groups in terms of time. Seventh month
Other Effect Size of Subjective Recovery Assessment Scale It shows how the applied occupational therapies affect the final and follow-up test scale scores of the intervention and control groups in terms of time. Seventh month
Primary Functional Remission of General Schzophrenia Scale (Pre Test) The scale is a 5-point Likert type scale consisting of 19 items. The minimum score obtained from the scale is 19 points and the maximum score is 95 points. High scores from the scale indicate high functionality, while low scores from the scale indicate low functionality. Scale scores were expected to be low in the pretest. 2 month
Primary Subjective Recovery Assessment Scale (Pre Test) The scale is a 5-point Likert type consisting of 17 items. The lowest score from the scale is 17 and the highest score is 85. Higher scores from the scale indicate that the individual perceives himself as more improved. Scale scores were expected to be low in the pretest. 2 month
Secondary Functional Remission of General Schzophrenia Scale (Post Test) The scale is a 5-point Likert type scale consisting of 19 items. The minimum score obtained from the scale is 19 points and the maximum score is 95 points. High scores from the scale indicate high functionality, while low scores from the scale indicate low functionality. "Functional Remission of General Schzophrenia Scale" score was expected to increase in the post test. Forth month
Secondary Subjective Recovery Assessment Scale (Post Test) The scale is a 5-point Likert type consisting of 17 items. The lowest score from the scale is 17 and the highest score is 85. Higher scores from the scale indicate that the individual perceives himself as more improved. It was expected that the score obtained from the scale in the post-test would be high. Forth month
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A